loading

Finanzdaten der Bluejay Diagnostics Inc-Aktie (BJDX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
5.11%
1.9854
1.8889 1.4846 1.3616 1.8953
Operating Income/Loss
5.11%
-1.9854
-1.8889 -1.4846 -1.3616 -1.8953
Nonoperating Income/Loss
17.46%
0.0288
0.0245 0.0527 -0.1204 -
Income/Loss From Continuing Operations Before Tax
4.94%
-1.9566
-1.8644 21.37 -1.482 -2.4754
Income/Loss From Continuing Operations After Tax
4.94%
-1.9566
-1.8644 -1.432 -1.482 -2.4754
Net Income/Loss
4.94%
-1.9566
-1.8644 -1.432 -1.482 -2.4754
Preferred Stock Dividends And Other Adjustments
-
- 13.22 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
150.38%
1.3871
0.554 -3.2613 9.5559 0.4832
Diluted Average Shares
150.38%
1.3871
0.554 -3.2613 9.5559 0.4832
Basic Earnings Per Share
58.16%
-1.41
-3.37 -112.37 -0.16 -5.12
Diluted Earnings Per Share
58.16%
-1.41
-3.37 -112.37 -0.16 -5.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 13.22 - -
$331.17
price down icon 0.16%
medical_devices STE
$248.65
price up icon 0.04%
medical_devices PHG
$27.64
price down icon 0.58%
$75.79
price down icon 0.47%
$74.08
price down icon 0.01%
medical_devices EW
$81.62
price up icon 0.47%
Kapitalisierung:     |  Volumen (24h):